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ABSTRACT 
Atherogenic dyslipidemia, characterized by an increased level of lipoprotein (a) and a decreased level of adi-
ponectin, is a major risk factor for cardiovascular diseases in diabetic patients. To reduce cardiovascular risk in 
diabetic patients, use of agents with antidiabetic and anti-atherogenic potential is required. Using an animal 
model of diabetes, we investigated the antiatherogenic potential of extracts of three medicinal plants: jujube, 
barberry, and saffron. For this, serum level of fasting blood glucose, lipid profile, malondialdehyde, total antiox-
idant capacity, adiponectin and lipoprotein (a) in diabetic control and extract treated groups were measured. Sta-
tistical analysis of measurements showed that serum levels of fasting blood glucose, triglyceride, and VLDL de-
creased significantly (P < 0.05) in all treated groups. Treatment with all extracts reduced lipid peroxidation and 
increased antioxidant capacity of the experimental diabetic groups. Serum adiponectin levels increased in all 
treated groups, whereas lipoprotein (a) levels decreased, most markedly when treated with jujube extract. Jujube, 
saffron, and barberry extracts are beneficial in ameliorating oxidative stress and atherogenic risk of diabetic rats. 
This highlights the benefits of further investigating the cardio-protective potential of medicinal plant extracts and 
evaluating their usefulness as cardio protective agents in clinical practice.  
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INTRODUCTION 
The increasing incidence of diabetes 
mellitus (DM) is a major global public health 
concern (Shane-McWhorter, 2005). Diabetes 
requires long-term medical care for glycemic 
control; decreases the quality of life because 
of complications (such as retinopathy, neu-
ropathy, and nephropathy); and leads to a 
large increase in medical expenditure (Chen 
et al., 2013). In addition, diabetes increases 
the risk of life-threatening diseases, includ-
ing cardiovascular diseases (CVDs) and can-
cer (Seshasai et al., 2011). The prevention of 
diabetes is therefore an issue of high priority. 
There is considerable evidence that hyper-
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glycemia-mediated oxidative stress is the 
major cause of complications of DM (Davi 
et al., 2005; Pari and Latha, 2005) and lipid 
peroxide-mediated tissue damage is observed 
in the development of type I and type II DM 
(Feillet-Coudray et al., 1999). Dyslipidemia 
is a major CVD risk factor in DM. The char-
acteristic features of diabetic dyslipidemia 
are high plasma triglyceride levels, low HDL 
cholesterol levels, and increased concentra-
tions of small dense LDL-cholesterol parti-
cles (Cohn and Sernyak, 2006). Several stud-
ies report high plasma levels of lipoprotein 
(a) [Lp(a)] in diabetic patients (Levitsky et 
al., 1991). Lp(a) consists of a carbohydrate-
rich protein named apo(a) linked by a single 
disulfide bond to apoB of an LDL-like lipo-
protein. Like LDL, Lp(a) is thought to be 
atherogenic. Because of the structural ho-
mology of apo(a) to plasminogen, it is also 
thought to have thrombogenic properties. 
The possibility of proatherogenic and pro-
thrombotic properties has led to a surge in 
research on the role of Lp(a) in atherosclero-
sis (Purnell et al., 1995). The atherogenic in-
dex of plasma (AIP), defined as the loga-
rithm (log) of the plasma concentration ratio 
of triglycerides to high-density lipoprotein 
(HDL) cholesterol, was recently proposed as 
a predictive marker for plasma atherogenici-
ty, and is positively correlated with the risk 
of CVD (Geohas et al., 2007). Adipose tissue 
is considered as an important endocrine or-
gan that secretes many biologically active 
substances, collectively known as adipo-
cytokines (Satoh et al., 2004). The major ad-
ipocytokine, adiponectin, is thought to play 
an important role in the regulation of cardio-
vascular and metabolic homeostasis. Adi-
ponectin increases tissue fat oxidation, lead-
ing to reduced levels of fatty acids and tissue 
triglyceride content, thus increasing insulin 
sensitivity (Satoh et al., 2004). Paradoxical-
ly, diabetes patients have decreased plasma 
adiponectin concentrations (Ashiuchi et al., 
2002), suggesting that hypoadiponectinemia 
is involved in the pathophysiology of DM. 
Another key element in development and 
progression of DM is oxidative stress, and 
use of antioxidants such as vitamins E and C 
improves the action of insulin in diabetic pa-
tients (Ceriello, 2000; Maritim et al., 2003). 
Accordingly, dietary supplementation with 
nutrients rich in antioxidants could amelio-
rate hyperglycemia-mediated stress in DM. 
Traditional antidiabetic plants might provide 
new oral hypoglycemic compounds which 
may counter the high cost and poor availabil-
ity of the current medicines. B. vulgaris, C. 
sativus, and Z. jujuba have antidiabetic and 
antioxidant effects on diabetic patient (Far-
khondeh and Samarghandian, 2014; Kaleem 
et al., 2014; Meliani et al. 2011). There is a 
direct correlation between antioxidant activi-
ty and phenolic content of Z. jujuba (Li et al, 
2005). B. vulgaris has a high antioxidant ca-
pacity due to its high levels of total phenolic, 
flavonoid (such as anthocyanin), and other 
polyphenolic compounds (Özgen et al, 
2012). The methanolic extract of Crocus sa-
tivus and its components such as safranal, 
crocin, etc. are reported to have radical scav-
enging activity (Bhargava, 2011). To better 
understand the action of B. vulgaris, C. sa-
tivus, and Z. jujuba in diabetes, and also to 
compare between effectiveness of the plants 
in treatment of diabetes, we studied the ef-
fects of hydroalcoholic and aqueous extracts 
of these plants on atherogenicity and risk of 
CVD in experimental diabetes.  
 
MATERIALS AND METHODS 
Animal experiments 
Adult male Wistar-derived rats with a 
mass of 200 to 220 g, bred and raised at the 
Birjand University of Medical Sciences ani-
mal quarters, housed at five rats per cage, 
were fed a rat chow diet (Pars Dam Co, Teh-
ran, Iran) and given water ad libitum. Diabe-
tes was induced by intraperitoneal injection 
of streptozotocin (60 mg/kg body mass) two 
weeks before starting treatment. Two weeks 
after injection, animals with plasma glucose 
levels exceeding 16.6 mM were considered 
to be diabetic. We randomly grouped 65 dia-
betic rats as follows: Groups 1 to 6 com-
prised of diabetic rats receiving hydroalco-
holic extracts of barberry, saffron, and jujube 
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at doses of 25 and 100 mg/kg, respectively. 
Groups 7 to 12 received an equal dose of 
aqueous extracts of these plants. Extracts 
were administered orally for 21 days. Dia-
betic (group 13) and healthy (group 14) con-
trol rats received water instead of extract. At 
the end of the 3-week treatment, blood sam-
ples were collected and biochemical parame-
ters were measured. Different concentrations 
of aqueous and alcoholic extracts of the 
plants were prepared on the basis of previous 
studies (Taati et al., 2011; Abdel-Zaher et al. 
2005). Results of the similar studies led us to 
use the selected doses of the medicinal plants 
(Meliani et al., 2011; Gulfraz et al., 2008). 
 
Measurement of FBG and lipid profile, and 
assessment of the atherogenic index 
Serum concentrations of FBG, triglycer-
ide, total cholesterol, and HDL-C were 
measured by photometric methods using di-
agnostic kits (Pars Azmun, Iran). The ather-
ogenic index of plasma (AIP), calculated as 
log [TG]/[HDL-C] is used as a significant 
predictor of atherosclerosis (Nwagha et al, 
2010). 
 
Measurement of Adiponectin and Lp(a) 
Serum adiponectin and Lp(a) concentra-
tions were estimated using specific enzyme-
linked immunosorbent assays (Glory Scienc-
es, Taiwan). For each group, assays were 
performed in duplicate. The experimental 
protocol was approved by the ethics commit-
tee of the Birjand University of Medical Sci-
ences. 
 
Ferric Reducing Antioxidant Power 
(FRAP) Assay 
Total serum antioxidant power was mea-
sured with the FRAP assay of Benzie and 
Strain (1996). In brief, antioxidants in serum 
reduce ferric iron to its ferrous form at low 
pH, leading to the formation of a colored fer-
rous-tripyridyltriazine complex. Two ml of 
FRAP reagent (300 mM sodium acetate buf-
fer pH 3.6, 10 mM 2,4,6-tris (2-pyridyl)-S-
triazine (TPTZ) in HCl, and 20 mM 
FeCl3.6H2O, mixed in a proportion of 10:1:1 
(v/v) was added to 50 µl of sample. After 
15 min, the absorbance at 593 nm was read 
(Benzie and Strain, 1996). 
 
Measurement of Thiobarbituric Acid Reac-
tive Substances (TBARS) 
Malondialdehyde (MDA) levels were 
measured using the Thiobarbituric acid reac-
tive substances (TBARS) method (Basu et 
al, 2009) in blood, collected from the heart at 
the end of treatment period. Plasma samples 
(300 µl) were added to 3 ml TBARS reagent 
(7.5 g trichloroacetic acid, 187 mg TBA, and 
6.25 ml chloridric acid), the mixture was 
heated in boiling water bath for 20 min, and 
the absorbance at 532 nm was determined. 
 
Statistical analysis 
Data was analyzed using One-Way 
ANOVA with SPSS version 16 software 
(SPSS Inc., Chicago, IL, USA). The statisti-
cal significance of differences in mean levels 
of FBS, Lp(a), etc. between the control and 
treated groups was evaluated using Student’s 
t-test. P-values of 0.05 or less were consid-
ered significant. Graphs were drawn with 
GraphPad Prism version 5 (GraphPad Soft-
ware Inc., La Jolla, CA, USA). 
 
RESULTS 
Compared with the diabetic control 
group, rats treated for 21 days with aqueous 
or hydroalcoholic extracts of B. vulgaris, C. 
sativus, and Z. jujuba had significantly re-
duced serum levels of FBG and triglyceride 
(p < 0.05) (Tables 1 and 2). Oral administra-
tion of these extracts also significantly im-
proved lipid profile of diabetic rats. Con-
sumption of B. vulgaris, C. sativus, and Z. 
jujuba reduced total cholesterol levels to 
those of the normoglycemic control group 
(Tables 1 and 2), and in contrast only Z. ju-
juba extracts at the two specified doses could 
increase HDL-C levels. Results represented 
in Tables 1 and 2, indicate hypolipidemic ef-
fects of the plants used in the present study. 
B. vulgaris, C. sativus, and Z. jujuba could 
improve increased level of triglycerides in 
diabetic rats. Compared to the nondiabetic 
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control group, diabetic control rats had sig-
nificantly increased serum Lp(a) levels (p < 
0.05) (Table 1). Treatment with the plant ex-
tracts reduced their Lp(a) levels to those of 
the nondiabetic control group. The result 
presented in Table 1 and 2 show that diabetic 
control group had lower levels of adiponec-
tin than normoglycemic group. Treatment 
with saffron, jujube, and barberry extracts 
increased their adiponectin levels. The AIP 
of diabetic rats decreased significantly fol-
lowing administration of saffron, jujube and 
barberry extracts (Tables 1 and 2). In Tables 
1 and 2, figures bearing different super-
scripts (a and b) are significantly different at 
p < 0 .05 (one way ANOVA and Duncan 
test). 
The plant extracts ameliorated hypergly-
cemia-mediated oxidative stress in diabetes 
and improved the antioxidant capacity of the 
experimental groups compared to diabetic 
control group (Figures 1 and 2). As shown in 
Figure 1, the hydroalcoholic extracts in-
creased antioxidant capacity more effectively 
than the aqueous extracts. This effect was 
more notable when using the jujube extract 
than with the other extracts. As shown in 
Figure 2, the medicinal plant extracts re-
duced lipid peroxidation. The saffron ex-
tracts were more effective than the other 
plant extracts, and the hydroalcoholic extract 
was more effective than the aqueous extract. 
 
 
 
 
Figure 1: The effect of hydroalcoholic and aque-
ous extract of barberry, saffron and jujube on an-
tioxidant capacity (Mean ± SD).  
* Significant (p < 0.05) difference between treated groups and 
diabetic control group. Black bars represent hydroalcoholic 
extract-treated groups. White bars represent aqueous ex-
tract-treated groups.  
 
 
 
 
Figure 2: The effect of hydroalcoholic and aque-
ous extract of barberry, saffron and jujube on 
malondialdehyde (Mean ± SD).  
* Significant (p < 0.05) difference between treated groups and 
diabetic control group. Black bars represent hydroalcoholic 
extract-treated groups. White bars represent aqueous ex-
tract-treated groups. 
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Table 1: The effects of hydroalcoholic extracts of B. Vulgaris, C. Sativus and Z. Jujuba on lipid profile and AIP in diabetic groups 
Parameters 
Experimental groups 1 
FBG (mmol/L) Triglycerides (mmol/L) 
Cholesterol 
(mmol/L) 
HDL-C 
(mmol/L) AIP Lp (a) (g/dl) 
Adiponectin 
(mg/L) 
Non-Diabetic control 8.3 ± 0.25 2 a 0.59 a 1.58 ± 0.11 a 0.91 a -0.19 29.4 ± 3.9a 4.65 ± 0.21 a 
Diabetic control 31.1  ±  2.3 b 1.83 b 2.74 ± 0.31 b 0.67 b 0.43 48.7 ± 5.8b 2.7 ± 0.1 b 
B. vulgaris (25 mg /kg ) 8.8  ±  0.12 a 0.65 a 1.64 ± 0.21 a 0.77 b -0.07 24.3 ± 6.9a 3.9 ± 0.12 a 
B. vulgaris (100 mg /kg) 9.03  ±  0.15 a 0.67 a 1.57 ± 0.13 a 0.87 b -0.11 33.6 ± 5a 4.3 ± 0.11 a 
C. sativus (25mg /kg ) 8.5 ± 0.46 a 0.46 a 1.68 ± 0.17 a 0.67 b -0.16 24.8 ± 6.4a 3.8 ± 0.1 a 
C. sativus (100 mg /kg) 8.4 ± 0.35 a 0.33 a 1.58 ± 0.11 a 0.75 b -0.35 20.7 ± 4.4a 4.1 ± 0.13 a 
Z. jujube (25 mg /kg ) 7.9 ± 0.5 a 0.43 a 1.67 ± 0.31a 1.40 a -0.52 24.8 ± 5.3a 3.5 ± 0.09 a 
Z. jujube (100 mg /kg ) 8.1  ±  0.42 a 0.24 a 1.64 ± 0.21 a 1.38 a -0.76 25.5 ± 7.3a 3.9 ± 0.1 a 
 
1 For details of experimental conditions and definition of AIP see the text.  
2 Data are presented as the Mean ±SD for five rats in each group. In each column, figures bearing different superscripts are significantly different at p < 0 .05 (one way ANOVA and Duncan test). 
AIP: Atherogenic index of plasma 
 
Table 2: The effects of aqueous extracts of B. Vulgaris, C. Sativus and Z. Jujuba on lipid profile and AIP in diabetic groups 
Parameters 
Experimental groups 1 
FBG (mmol/L) Triglycerides (mmol/L) 
Cholesterol 
(mmol/L) 
HDL-C 
(mmol/L) AIP Lp (a) (g/dl) 
Adiponectin 
(mg/L) 
Non-Diabetic control 8.3 ± 0.25 2 a 0.59 a 1.58 ± 0.11 a 0.91 a -0.19 29.4 ± 3.9a 4.65 ± 0.21 a 
Diabetic control 31.1  ±  2.3 b 1.83 b 2.74 ± 0.31 b 0.67 b 0.43 48.7 ± 5.8b 2.7 ± 0.1 b 
B. vulgaris (25 mg /kg ) 8.8  ±  0.12 a 0.65 a 1.74 ± 0.21 a 0.9 a -0.14 32.12 ± 4.87a 4.4 ± 0.12 a 
B. vulgaris (100 mg /kg) 9.1  ±  0.15 a 0.55 a 1.67 ± 0.13 a 0.91 a -0.22 28.2 ± 6.66a 4.8 ± 0.13 a 
C. sativus (25mg /kg ) 9.3 ± 0.46 a 0.68 a 1.78 ± 0.17 a 0.88 a -0.11 33.78 ± 5.95a 4.5 ± 0.12 a 
C. sativus (100 mg /kg) 8.8 ± 0.35 a 0.52 a 1.69 ± 0.11 a 0.89 a -0.23 16 ± 5.03a  ± 0.14 a 
Z.jujuba (25 mg /kg ) 8.4 ± 0.5 a 0.43 a 1.82 ± 0.31 b 0.99 a -0.36 37.54 ± 3.34a 4.2 ± 0.11 a 
Z.jujuba (100 mg /kg ) 8.9  ±  0.42 a 0.4 a 1.65 ± 0.21 a 1.1 a -0.44 24.12 ± 3.28a 3.9 ± 0.1 a 
 
1 For details of experimental conditions and definition of AIP see the text.  
2 Data are presented as the Mean ±SD for five rats in each group. In each column, figures bearing different superscripts are significantly different at p < 0 .05 (one way ANOVA and Duncan test). 
AIP: Atherogenic index of plasma 
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DISCUSSION 
It is well known that the incidence of 
CVD in patients with diabetes is high. Alt-
hough CVD pathogenesis in diabetes is mul-
tifactorial, dyslipidemia is a powerful risk 
factor (Suryawanshi et al., 2006). In addi-
tion, oxidative stress has a key role in this 
process (Hambali et al., 2011). In the present 
study antiatherogenic and antioxidant effects 
of three medicinal plants B. vulgaris, C. sa-
tivus, and Z. jujuba were compared. Our re-
sults show that saffron, jujube, and barberry 
extracts may have antiatherogenic effects in 
diabetic rat models, which is likely to be re-
lated to the antioxidant capacities of the ex-
tracts. We found that treating diabetic rats 
with aqueous and hydroalcoholic extracts of 
B. vulgaris, C. sativus, and Z. jujuba effec-
tively decreased their elevated FBS levels. 
The hypoglycemic effects of the medicinal 
plants were previously reported (Meliani et 
al., 2011). Oral administration of hydroalco-
holic extracts of C. sativus, B. vulgaris, and 
Z. jujuba significantly (P < 0.05) increased 
the serum adiponectin levels of diabetic rats. 
Considering the results of similar studies, we 
may conclude that adiponectin has a reverse 
relationship with glucose, triglyceride, 
VLDL, and cholesterol, and a direct relation-
ship with HDL-C (Qiao et al., 2008). Given 
the role of adiponectin in glucose and lipid 
metabolism, it seems that the hypoglycemic 
and hypolipidemic effects of the plants could 
be affected through changes in adiponectin 
levels. The AIPs of the different groups indi-
cate that saffron, jujube and barberry extracts 
have anti-atherogenic effects (Table 1, 2). 
Concentrations of Lp(a) were higher in the 
diabetic control group than in the nondiabet-
ic control group (Table 1). Elevated levels of 
Lp(a) in type I DM were found in other stud-
ies (Haffner, 1993; Giacco and Brownlee, 
2010). Serum Lp(a) levels significantly de-
creased in all treated groups (Tables 1 and 
2). These medicinal plant extracts may there-
fore reduce the high risk of cardiovascular 
complications in experimental diabetes. Use 
of antioxidant-rich nutrients to reduce ather-
ogenic modifications has been studied previ-
ously (Aviram et al., 2000). Our measure-
ment of antioxidant capacity in diabetic rats 
revealed high glucose- mediated oxidative 
stress, which was relieved by oral consump-
tion of jujube, saffron, and barberry extracts. 
Among the different plant extracts used in 
our study, jujube had a higher antioxidant 
capacity. It appears that use of natural 
sources of antioxidants such as barberry, saf-
fron, and especially jujube, is useful in 
treatment of diabetes and associated CVD. It 
was suggested that the possible antioxidant 
activities of extracts are due to the presence 
of tannins, carotenes, and flavonoids in some 
Ziziphus species (Gao et al., 2012; Taati et 
al., 2011) and a direct correlation was found 
between the antioxidant activity and phenol-
ic contents (Li et al., 2005). Adiponectin as 
an antioxidant is inversely correlated with 
oxidative stress, inflammation, and chronic 
diseases such as diabetes (Chen et al., 2012). 
Dyslipidemia is a common feature of DM. 
Our study supports the finding that the dia-
betic dyslipidemia comprising of elevated to-
tal cholesterol, TG, VLDL, Lp(a), and low 
HDL-C and adiponectin levels persists in di-
abetes. Lp(a) may be considered as an im-
portant independent risk marker to identify 
diabetes patients who may develop CVD. In 
this study, we found that jujube, saffron, and 
barberry extracts especially hydroalcoholic 
extract could reduce risk of CVD by improv-
ing the lipid profile, AIP, and Lp(a) levels. 
TG and HDL are the parameters that affect 
AIP. In the present study, herbal medicine 
consumption improved lipid profile, also 
AIP decreased to normoglycemic group. Ac-
cording to the role of Lp(a) in atherogenicity, 
and considering that consumption of the ex-
tracts especially jujube reduced Lp(a), we 
can expect reduced level of AIP in treatment 
groups. A more accurate explanation will ob-
tain from consumption of the extracts by 
normoglycemic rats and investigation of 
changes in lipid profile and AIP of the exper-
imental groups. According to the results of 
the FRAP assay, oral administration of the 
extracts increased total antioxidant capacity 
and AIP in treatment groups could be in as-
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sociate with total antioxidant capacity. These 
beneficial effects especially for saffron and 
jujube could be taken into consideration 
when designing new drugs. Based on our da-
ta, adding jujube and saffron extracts to diets 
for diabetic patients may help to improve 
control of diabetic complications. Further 
experimental and clinical investigation is 
needed to determine the effective dosage of 
the plant extracts in clinical practice.  
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